Wallberg Kenny A Rodriguez-Macias, Keros Victoria, Hovatta Outi
Division of Obstetrics and Gynecology, Fertility Unit, Karolinska University Hospital-Huddinge, Stockholm, Sweden.
Pediatr Blood Cancer. 2009 Aug;53(2):254-60. doi: 10.1002/pbc.21995.
There are several methods of fertility preservation available for female patients facing infertility following gonadotoxic treatment of cancer or systemic disease. Embryos, oocytes or ovarian tissue can be cryopreserved and stored until the time when the patient is cured of her main disease and is expecting parenthood. The individual's choice depends on the nature and stage of the main disease, expected treatment, their condition, and age and existence of the partner. It is important to inform all such women about the options, and together with them, choose the most appropriate ones. It is often possible to save ovarian tissue even though the first chemotherapy courses have been undergone, but many more follicles can be stored before cancer treatment.
对于因癌症或全身性疾病接受性腺毒性治疗而面临不孕的女性患者，有几种生育力保存方法。胚胎、卵母细胞或卵巢组织可以冷冻保存，直到患者治愈主要疾病并期望生育。个人的选择取决于主要疾病的性质和阶段、预期的治疗、患者的状况、年龄以及伴侣的情况。告知所有此类女性这些选择并与她们一起选择最合适的方法非常重要。即使已经接受了首轮化疗疗程，通常也有可能保存卵巢组织，但在癌症治疗前可以保存更多的卵泡。
